Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_assertion type Assertion NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_head.
- NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_assertion description "[Factors associated with a higher probability of IFIs were donor's MBL-low genotype (38% vs 12%, p = 0.01), recipient's MASP2 variant (67% vs 14%, p = 0.01), and acute graft-versus-host disease (GVHD) grades II to IV (27% vs 11%, p = 0.04); in the multivariate analysis MBL-low genotype (relative risk [RR] 7.3, p = 0.003), MASP2 variant (RR 6.4, p = 0.002), and acute GVHD II to IV (RR 3.8, p = 0.02) retained independent prognostic value.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_provenance.
- NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_assertion evidence source_evidence_literature NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_provenance.
- NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_assertion SIO_000772 16982337 NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_provenance.
- NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_assertion wasDerivedFrom befree-2016 NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_provenance.
- NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_assertion wasGeneratedBy ECO_0000203 NP569824.RA8xgWcR56oH4UUiIgRT3QYuvqP1j9AT3i4p24MkrHnsE130_provenance.